In an era marked by remarkable strides in science and technology, drug discovery remains an increasingly formidable endeavor. Historically low success rates in developing new therapeutics, compounded by a steady decline in productivity, pose significant challenges. Over the past decade, the machine learning (ML) community has shown growing interest and embarked on pioneering work, yet many of these efforts remain nascent.
MLDD aims to bring together ML for drug discovery experts, innovators, and enthusiasts from the machine learning, biotechnology and drug discovery domains in London, UK to converge, exchange ideas, and forge new paths in revolutionizing therapeutic development.
The event is open for all in the community kindly sponsored by GSK plc. See you there!